339 related articles for article (PubMed ID: 21136203)
1. Intracellular osteopontin (iOPN) and immunity.
Inoue M; Shinohara ML
Immunol Res; 2011 Apr; 49(1-3):160-72. PubMed ID: 21136203
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists.
Zhao W; Wang L; Zhang L; Yuan C; Kuo PC; Gao C
J Biol Chem; 2010 Jul; 285(27):20452-61. PubMed ID: 20427276
[TBL] [Abstract][Full Text] [Related]
3. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.
Bastos ACSDF; Gomes AVP; Silva GR; Emerenciano M; Ferreira LB; Gimba ERP
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769264
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses.
Inoue M; Moriwaki Y; Arikawa T; Chen YH; Oh YJ; Oliver T; Shinohara ML
J Immunol; 2011 Jan; 186(1):19-23. PubMed ID: 21135164
[TBL] [Abstract][Full Text] [Related]
5. Intracellular osteopontin negatively regulates toll-like receptor 4-mediated inflammatory response via regulating GSK3β and 4EBP1 phosphorylation.
Yang H; Ye X; Zhang X; Li X; Fu Q; Tang Z
Cytokine; 2018 Aug; 108():89-95. PubMed ID: 29587154
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
Fan X; He C; Jing W; Zhou X; Chen R; Cao L; Zhu M; Jia R; Wang H; Guo Y; Zhao J
Cancer Res; 2015 Jan; 75(1):86-97. PubMed ID: 25398438
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology.
Buback F; Renkl AC; Schulz G; Weiss JM
Exp Dermatol; 2009 Sep; 18(9):750-9. PubMed ID: 19558497
[TBL] [Abstract][Full Text] [Related]
8. Two different isoforms of osteopontin modulate myelination and axonal integrity.
Nilsson G; Mottahedin A; Zelco A; Lauschke VM; Ek CJ; Song J; Ardalan M; Hua S; Zhang X; Mallard C; Hagberg H; Leavenworth JW; Wang X
FASEB Bioadv; 2023 Aug; 5(8):336-353. PubMed ID: 37554545
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin (OPN)/SPP1: from its biochemistry to biological functions in the innate immune system and the central nervous system (CNS).
Lin EY; Xi W; Aggarwal N; Shinohara ML
Int Immunol; 2023 Apr; 35(4):171-180. PubMed ID: 36525591
[TBL] [Abstract][Full Text] [Related]
10. Secreted-Osteopontin Contributes to Brown Adipogenesis In Vitro via a CD44-Dependent Pathway.
Wang M; Guo Y; Zhou Y; Yuan W; Li H; Xiong S; Wang K; Zeng G; Huang Q
Horm Metab Res; 2019 Nov; 51(11):741-748. PubMed ID: 31295749
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.
Clemente N; Raineri D; Cappellano G; Boggio E; Favero F; Soluri MF; Dianzani C; Comi C; Dianzani U; Chiocchetti A
J Immunol Res; 2016; 2016():7675437. PubMed ID: 28097158
[TBL] [Abstract][Full Text] [Related]
12. Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin.
Kanayama M; Xu S; Danzaki K; Gibson JR; Inoue M; Gregory SG; Shinohara ML
Nat Immunol; 2017 Sep; 18(9):973-984. PubMed ID: 28671690
[TBL] [Abstract][Full Text] [Related]
13. Secreted osteopontin from CD4
Aggarwal N; Deerhake ME; DiPalma D; Shahi SK; Gaggioli MR; Mangalam AK; Shinohara ML
Cell Rep; 2021 Dec; 37(13):110170. PubMed ID: 34965439
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
Uede T
Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin expression during early cerebral ischemia-reperfusion in rats: enhanced expression in the right cortex is suppressed by acetaminophen.
Baliga SS; Merrill GF; Shinohara ML; Denhardt DT
PLoS One; 2011 Jan; 6(1):e14568. PubMed ID: 21283687
[TBL] [Abstract][Full Text] [Related]
16. Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response.
Zhao K; Zhang M; Zhang L; Wang P; Song G; Liu B; Wu H; Yin Z; Gao C
Sci Rep; 2016 Mar; 6():23771. PubMed ID: 27026194
[TBL] [Abstract][Full Text] [Related]
17. OPN promotes pro-inflammatory cytokine expression via ERK/JNK pathway and M1 macrophage polarization in Rosacea.
Tang S; Hu H; Li M; Zhang K; Wu Q; Liu X; Wu L; Yu B; Chen X
Front Immunol; 2023; 14():1285951. PubMed ID: 38250077
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
Yushi Q; Li Z; Von Roemeling CA; Doeppler H; Marlow LA; Kim BY; Radisky DC; Storz P; Copland JA; Tun HW
Oncotarget; 2016 May; 7(22):32156-71. PubMed ID: 27050077
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy.
Frenzel DF; Weiss JM
Expert Rev Clin Immunol; 2011 Jan; 7(1):93-109. PubMed ID: 21162653
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity.
Jia R; Liang Y; Chen R; Liu G; Wang H; Tang M; Zhou X; Wang H; Yang Y; Wei H; Li B; Song Y; Zhao J
Cell Death Dis; 2016 Dec; 7(12):e2564. PubMed ID: 28032860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
